SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10080Yes. But that being said, the stock was too cheap before so it remains about thRobohogs-5/18/2007
10079Do you think this justifies the 15% haircut the stock is taking?I_Banker-5/18/2007
10078I have seen 25% and it is marginal sales with something like a 60-70% operating Robohogs-5/18/2007
1007715% drop in price for an estimate of 15% drop in the sales of one drug? Seems A.J. Mullen-5/18/2007
10076BOSTON, May 18 (Reuters) - Medicare plans to cut reimbursement levels for SepracA.J. Mullen-5/18/2007
10075SEPR will be filing a lawsuit I assume. SEPR now firesaling. JonRobohogs-5/18/2007
10074Xenopex Summer Street Research Partners in Boston today downgraded The noA.J. Mullen-5/18/2007
10073down over $5... not sure .... is it that generic A is hurting more than presumedIamarangerboy-5/18/2007
10072What story or rumor am I missing? Anyone have a clue what's happened to the Sidney Street-5/18/2007
10071Anyone go today? I missed for the second straight year.Rocky9-5/15/2007
10070May 3 week L 146,904 This compares to April 6 week of 140,686 and March 2 weeRobohogs-5/15/2007
10069surprised at how rapid that was. I presume that he has integrated well with the Iamarangerboy-5/15/2007
10068Sepracor Announces Management Transition Tuesday May 15, 7:00 am ET Adrian AdamsIcebrg-5/15/2007
10067Brovana competition. Message 23540450 JonRobohogs-5/14/2007
10066what is with the trade volume???? Iamarangerboy-5/11/2007
10065A little stumble for competitor Somaxon: >>Somaxon Pharmaceuticals Providtuck-5/9/2007
10064Ambien Cr is finally now growing slower than Lunesta on week over week/month oveRobohogs-5/9/2007
10063More interesting info: Zyrtec has gained 2-3% points of share over last 2 yearsRobohogs-5/9/2007
10062Can find no info on Brovana. Sorry. Did see updated info on Xop HFA in graph fRobohogs-5/9/2007
10061Hammock Time Posted by Heather Won Tesoriero May 4, 2007, 8:21 pm As the HealDoc Bones-5/8/2007
10060April 27 week data: L 139,007 MDI 55,471 Share was up slightly for Lunesta TRRobohogs-5/8/2007
10059Interesting - the prices I saw on net for Xop ranged from $50-80 for a small viaRobohogs-5/1/2007
10058This is a pure guess - but I would assume flat to Xop nebulizer since basically Robohogs-5/1/2007
10057Any idea what the $/Rx is for brovana? Will be interesting to see what the slerkrw-4/30/2007
10056Daa for most recent week ending 10 days ago - April 20: L 138,156 not bad forRobohogs-4/30/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News